BMRA Biomerica, Inc: Bozor qiymatining balans qiymatiga nisbati

Biomerica (BMRA) korporativ emblemasi va logotipi

GURU.Markets vaqtinchalik grafigidagi bozor qiymatining buxgalteriya qiymatiga nisbati tendentsiyasi uy sharoitida gastrointestinal testlar uchun patentlar bilan himoyalangan Biomerica, Inc. (BMRA) kompaniyasining holatini namoyish etadi. Kompaniya o'z diagnostikalarining chakana savdo sotuvlarini kengaytirayotgan bir paytda 2.25 belgisi joriy ko'rsatkich vazifasini o'taydi. Biznesning muvaffaqiyati ilmiy aniqlik va yuqori sifatli tadqiqotlar madaniyatini rivojlantiruvchi bioximiklarning malakasiga asoslangan.

Biomerica Inc (BMRA) - Bozor qiymatining balans qiymatiga koeffitsiyenti 04.07.2022dan 29.10.2026gacha
Biomerica, Inc yetakchi tovari

Ushbu ko'rsatkich aktivlarning bozor qiymatini ularning balans qiymatiga nisbatan aniqlaydi va kelajakdagi o'sish uchun qo'shimcha qiymatni o'lchaydi. Biomerica, Inc. (BMRA) kompaniyasi uchun, uning ishlab chiqarish va IT infratuzilmasini autsorsing modeliga asoslagani sababli, ushbu koeffitsient nomoddiy afzalliklarning qiymatini aks ettiradi. Bozor kapitalizatsiyasining balans kapitalizatsiyasiga nisbatini tahlil qilish orqali investor biznes modeliga bo'lgan bozor ishonchi dinamikasini kuzatishi mumkin. Ushbu metrikaning pasayishi aktivlarning qadrsizlanganini yoki tizimli inqiroz mavjudligini anglatadi.

Raqobatchilar tahlili

A: Bozor kapitallashuvining balans qiymatiga nisbati|questdiagnostics.com (DGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Illumina|Kapitallashuvning sof aktivlarga nisbati Exact Sciences Corp (EXAS)|Bozor kapitallashuvining balans qiymatiga nisbati RVTY|BIO - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati NNNN (Anbio Biotechnology)|SHC: Kapitallashuvning balans qiymatiga nisbati|QuidelOrtho Corporation - Bozor kapitallashuvining balans qiymatiga nisbati|OPK - Bozor kapitallashuvining balans qiymatiga nisbati|CareDx (CDNA) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati MRVI|FLGT (Fulgent Genetics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati fluidigm.com|Bozor qiymatining balans qiymatiga nisbati Cytek Biosciences (CTKB)|Bozor qiymatining balans qiymatiga nisbati OSUR (OraSure Technologies, Inc.)|Exagen - Kapitallashuvning sof aktivlarga nisbati|MDxHealth, Inc. (MDXH) - Bozor qiymatining balans qiymatiga koeffitsiyenti|LUCD - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Prenetics Global PRE|IMDX: Bozor kapitallashuvining balans qiymatiga nisbati|TRIB - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati ProPhase|Ainos Corporation (AIMD) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati CODX|Bozor qiymatining balans qiymatiga nisbati HSCS (heartsciences.com)|Bozor kapitallashuvining balans qiymatiga nisbati CDIO (Cardio Diagnostics Holdings)|Balans qiymatiga nisbatan bozor kapitallashuvi Virax Biolabs Group Limited (VRAX)|BJDX - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Aspira Women's Health Inc|Accelerate Diagnostics (AXDX) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati CENTOGENE|ENZ (Enzo Biochem Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Fresh2 FRES|Bozor qiymatining balans qiymatiga nisbati Genetic Technologies (GENE)|ME (23andMe Inc) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati PMD (Psychemedics)